Fortress Biotech Reports Record Third Quarter 2021 Financial Results and Recent Corporate Highlights Nov 15, 2021
Mustang Bio Reports Third Quarter 2021 Financial Results and Recent Corporate Highlights Nov 12, 2021
Mustang Bio Announces Exclusive Worldwide License Agreement with Leiden University Medical Centre for Clinical-Stage Lentiviral Gene Therapy with Curative Potential for RAG1 Severe Combined Immunodeficiency Nov 10, 2021
Mustang Bio Announces MB-106 CD20-Targeted CAR T Data Selected for Presentation at 63rd American Society of Hematology (ASH) Annual Meeting Nov 04, 2021